Adtalem Global Education, Inc.

  • Market Cap: Small Cap
  • Industry: Tour, Travel Related Services
  • ISIN: US00737L1035
USD
96.11
1.76 (1.87%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Adtalem Global Education, Inc. stock-summary
stock-summary
Adtalem Global Education, Inc.
Tour, Travel Related Services
Adtalem Global Education Inc. is a provider of workforce solutions. The Company operates through two segments: Medical and Healthcare, and Financial Services. Medical and Healthcare segment offers degree and non-degree programs in the medical and healthcare postsecondary education industry. Medical and Healthcare segment includes the operations of Chamberlain University, American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine. Financial Services segment offers test preparation, certifications, conferences, seminars, memberships, and subscriptions to business professionals in the areas of accounting, anti-money laundering, banking, and mortgage industries. Financial Services segment includes the operations of the Association of Certified Anti-Money Laundering Specialists, Becker Professional Education, OnCourse Learning and EduPristine.
Company Coordinates stock-summary
Company Details
500 W Monroe St Fl 28 , CHICAGO IL : 60661-3773
stock-summary
Tel: 1 630 51577001 312 6511481
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 95 Schemes (62.01%)

Foreign Institutions

Held by 145 Foreign Institutions (9.6%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Ms. Lisa Wardell
Chairman of the Board, President, Chief Executive Officer
Mr. William Burke
Lead Independent Director
Ms. Donna Hrinak
Independent Director
Ms. Georgette Kiser
Independent Director
Mr. Lyle Logan
Independent Director
Mr. Michael Malafronte
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
457 Million
(Quarterly Results - Jun 2025)
Net Profit:
54 Million
stock-summary
Industry

Tour, Travel Related Services

stock-summary
Market cap

USD 9,248 Million (Small Cap)

stock-summary
P/E

37.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.26

stock-summary
Return on Equity

16.46%

stock-summary
Price to Book

6.45